VESALIO was proud to be a sponsor of the SLICE 2019 congress conducted in Nice, September 30 to October 2, 2019. Vesalio representatives met with existing and potential NeVa users and discussed their clinical cases.
88 year old female patient presented with a NIHSS of 15. The patient was found on the floor of her bathroom, with left side hemiplegia.
VESALIO was proud to sponsor the ESMINT Society 11th annual meeting in Nice, from 4-6 September 2019.
Right ICA Tip Occlusion 1st Pass Success with “NeVa T” (4.5 x 37 mm) 75 year old female patient presented with NIHSS of 14. Time from Onset was 1,5 hours at the time of admission to Medical Park stroke center. The patient had a medical history of hypertenssion and atrial fibrillation and was on a once/day…
75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset. It was noted that the patient had had a knee implant surgery 3 days prior to her stroke. Imaging confirmed distal left MCA occlusion.
81 year old male patient presented with NIHSS of 21. The patient was last seen well 6.5 hours ago. Imaging confirmed Left MCA occlusion.
Vesalio made its exciting debut as an exhibitor at the LINNC congress. Several current users and many physicians interested in NeVa visited the Vesalio exhibit to discuss recently published First-in-Man study data and view the new, highly innovative NeVa designs.
Vesalio announces it has obtained its second CE Approval spanning multiple new NeVa™ product designs and technology. The new generation NeVa devices expand on the Drop Zone™ and Smart Marker™ technologies.
Vesalio announces it has recently raised $5 million in funding. The capital will support the continued global expansion of the NeVa™ Neurothrombectomy System, finance key clinical studies and launch new product introductions.
VESALIO’s™ NeVa attracted interest from the participants from all over the world at the 19th World Live Neurovascular Conference which took place in Barcelona from 1st to 3rd May.